Denis Guyonnet
About
In The Last Decade
Denis Guyonnet
50 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Biology 2.0k
- Food Science 948
- Gastroenterology 947
- Physiology 827
- Nutrition and Dietetics 582
Countries citing papers authored by Denis Guyonnet
This map shows the geographic impact of Denis Guyonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Guyonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Guyonnet more than expected).
Fields of papers citing papers by Denis Guyonnet
This network shows the impact of papers produced by Denis Guyonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Guyonnet. The network helps show where Denis Guyonnet may publish in the future.
Co-authorship network of co-authors of Denis Guyonnet
This figure shows the co-authorship network connecting the top 25 collaborators of Denis Guyonnet. A scholar is included among the top collaborators of Denis Guyonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Guyonnet. Denis Guyonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further breakdown → | 287 |
| 3 | 140 | |
| 4 | 5 | |
| 5 | 31 | |
| 6 | 21 | |
| 7 | 101 | |
| 8 | 37 | |
| 9 | Upregulation of wide dynamic range afferent pathways in hypersensitive patients with Irritable Bowel Syndrome (IBS): A role for psychosocial factors? | 2 |
| 10 | Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation | 23 |
| 11 | 71 | |
| 12 | Fermented milk containing the Bifidobacterium animalis, DN-173 010 (FM) improves abdominal distension, bloating and transit in irritable bowel syndrome with constipation | 4 |
| 13 | 44 | |
| 14 | 15 | |
| 15 | Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial | 14 |
| 16 | 265 | |
| 17 | 20 | |
| 18 | 82 | |
| 19 | 111 | |
| 20 | 27 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.